Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

    Reumatologia Clinica, Vol. 19, Núm. 6, pp. 312-318

2022

  1. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

    Reumatologia Clinica, Vol. 18, Núm. 1, pp. 33-41

2021

  1. HLA association with the susceptibility to anti-synthetase syndrome

    Joint Bone Spine, Vol. 88, Núm. 3

2020

  1. Influence of MUC5B gene on antisynthetase syndrome

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients

    Rheumatology International, Vol. 39, Núm. 11, pp. 1875-1882

2018

  1. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27

  2. Recommendations for the use of parenteral methotrexate in rheumatic diseases

    Reumatologia Clinica, Vol. 14, Núm. 3, pp. 142-149

2015

  1. Recomendaciones para el uso del metotrexato en artritis reumatoide: Incremento y reducción de dosis y vías de administración

    Reumatologia Clinica, Vol. 11, Núm. 1, pp. 3-8

2012

  1. Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol

    Pain Practice, Vol. 12, Núm. 4, pp. 290-306

2008

  1. Primary Sjögren syndrome in Spain: Clinical and immunologic expression in 1010 patients

    Medicine, Vol. 87, Núm. 4, pp. 210-219

2006

  1. Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145